Dobosz M, Hac S, Mionskowska L, Dobrowolski S, Wajda Z
The Second Department of Surgery, Medical University of Gdańsk, Poland.
Pharmacol Res. 1997 Aug;36(2):123-8. doi: 10.1006/phrs.1997.0200.
Local microcirculatory dysfunction within the pancreatic gland might be an important factor in the conversion of oedematous to necrotizing pancreatitis. Therapeutic agents, improving the pancreatic blood flow, might be valuable in acute pancreatitis treatment. An influence of nitric oxide, heparin and procaine treatment on microcirculatory values in acute pancreatitis (AP) in rats was investigated. Acute pancreatitis was induced by i.p. injection of cerulein in four doses of 15 microg kg-1 each at 1-h intervals. The rats with pancreatitis were divided into five groups, 12 animals each. One group remained without treatment, four groups were treated i.p. either with NO synthase inhibitor L-NNA (2x25 mg kg-1 or heparin 2x2.5 mg kg-1 or L-arginine 2x100 mg kg-1 or procaine 2x25 mg kg-1. Five control groups, ten animals each, received saline, L-NNA, heparin, L-arginine or procaine only. Five hours after the first ceruleine injection microcirculatory values within the pancreas were measured by means of laser Doppler flowmetry. Acute pancreatitis caused a significant drop of microcirculatory value to 37% of the basal value. The L-NNA administration resulted in a further insignificant reduction of the pancreatic blood flow to 34%. An improvement of microcirculation was observed in rats with pancreatitis receiving heparin (76%) and L-arginine (72%). Procaine had no effect on microcirculatory disturbances within the pancreas in rats with pancreatitis. Cn-induced acute pancreatitis (AP) causes microcirculatory deterioration within the pancreas. Heparin and nitric oxide donor, L-arginine, might be considered as therapeutic agents, improving the diminished pancreatic tissue perfusion observed in acute pancreatitis. Procaine does not improve the pancreatic blood flow in acute pancreatitis.
胰腺内的局部微循环功能障碍可能是水肿性胰腺炎转变为坏死性胰腺炎的一个重要因素。改善胰腺血流的治疗药物可能对急性胰腺炎的治疗具有重要价值。本研究探讨了一氧化氮、肝素和普鲁卡因治疗对大鼠急性胰腺炎(AP)微循环指标的影响。通过腹腔注射蛙皮素诱导急性胰腺炎,每隔1小时注射4剂,每剂15μg/kg。将胰腺炎大鼠分为五组,每组12只动物。一组不进行治疗,其余四组分别腹腔注射一氧化氮合酶抑制剂L-NNA(2×25mg/kg)、肝素(2×2.5mg/kg)、L-精氨酸(2×100mg/kg)或普鲁卡因(2×25mg/kg)。五个对照组,每组10只动物,分别仅接受生理盐水、L-NNA、肝素、L-精氨酸或普鲁卡因。首次注射蛙皮素5小时后,通过激光多普勒血流仪测量胰腺内的微循环指标。急性胰腺炎导致微循环指标显著下降至基础值的37%。给予L-NNA后,胰腺血流进一步轻微下降至34%。接受肝素(76%)和L-精氨酸(72%)治疗的胰腺炎大鼠的微循环得到改善。普鲁卡因对胰腺炎大鼠胰腺内的微循环障碍没有影响。蛙皮素诱导的急性胰腺炎(AP)会导致胰腺内微循环恶化。肝素和一氧化氮供体L-精氨酸可被视为治疗药物,可改善急性胰腺炎时观察到的胰腺组织灌注减少。普鲁卡因不能改善急性胰腺炎时的胰腺血流。